Cargando…
Zoledronic Acid as a Novel Dual Blocker of KIR6.1/2-SUR2 Subunits of ATP-Sensitive K(+) Channels: Role in the Adverse Drug Reactions
Zoledronic acid (ZOL) is used as a bone-specific antiresorptive drug with antimyeloma effects. Adverse drug reactions (A.D.R.) are associated with ZOL-therapy, whose mechanics are unknown. ZOL is a nitrogen-containing molecule whose structure shows similarities with nucleotides, ligands of ATP-sensi...
Autores principales: | Maqoud, Fatima, Scala, Rosa, Tragni, Vincenzo, Pierri, Ciro Leonardo, Perrone, Maria Grazia, Scilimati, Antonio, Tricarico, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8465290/ https://www.ncbi.nlm.nih.gov/pubmed/34575427 http://dx.doi.org/10.3390/pharmaceutics13091350 |
Ejemplares similares
-
Zoledronic Acid Blocks Overactive Kir6.1/SUR2-Dependent K(ATP) Channels in Skeletal Muscle and Osteoblasts in a Murine Model of Cantú Syndrome
por: Scala, Rosa, et al.
Publicado: (2023) -
Zoledronic Acid Modulation of TRPV1 Channel Currents in Osteoblast Cell Line and Native Rat and Mouse Bone Marrow-Derived Osteoblasts: Cell Proliferation and Mineralization Effect
por: Scala, Rosa, et al.
Publicado: (2019) -
Diabetes induced by gain-of-function mutations in the Kir6.1 subunit of the K(ATP) channel
por: Remedi, Maria S., et al.
Publicado: (2017) -
Kir6.1- and SUR2-dependent K(ATP) overactivity disrupts intestinal motility in murine models of Cantú syndrome
por: York, Nathaniel W., et al.
Publicado: (2020) -
Involvement of SUR2/Kir6.1 channel in the physiopathology of pulmonary arterial hypertension
por: Le Ribeuz, Hélène, et al.
Publicado: (2023)